TrianglePUBLICATIONS · 17679727
Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2007 Sep 1
- First author
- Orlowski RZ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Orlowski RZ
- type
- Author
- name
- Nagler A
- type
- Author
- name
- Sonneveld P
- type
- Author
- name
- Bladé J
- type
- Author
- name
- Hajek R
- type
- Author
- name
- Spencer A
- type
- Author
- name
- San Miguel J
- type
- Author
- name
- Robak T
- type
- Author
- name
- Dmoszynska A
- type
- Author
- name
- Horvath N
- type
- Author
- name
- Spicka I
- type
- Author
- name
- Sutherland HJ
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Orlowski RZ
- type
- Author
- name
- Nagler A
- type
- Author
- name
- Sonneveld P
- type
- Author
- name
- Bladé J
- type
- Author
- name
- Hajek R
- type
- Author
- name
- Spencer A
- type
- Author
- name
- San Miguel J
- type
- Author
- name
- Robak T
- type
- Author
- name
- Dmoszynska A
- type
- Author
- name
- Horvath N
- type
- Author
- name
- Spicka I
- type
- Author
- name
- Sutherland HJ
- type
- Author
- bibliography ids
- nci-bib-59235c7bfd71786717aba9e6
- book metadata
- content sha256
- de348e30f6b140173d42f447ca02c8a68898e72ee6c670b83c7210a2fe9b6bc9
- document type
- citation
- dois
- 10.1200/JCO.2006.10.5460
- electronic publication date
- display
- 2007 Aug 6
- precision
- day
- year
- 2007
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:17679727
- immutable id
- pubmed:17679727@de348e30f6b140173d42f447ca02c8a68898e72ee6c670b83c7210a2fe9b6bc9
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 25
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3892-901
- volume
- 25
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 17679727
- provenance
- batch id
- de363a11f4b1613edab0
- provider
- NCBI PubMed ESummary
- record sha256
- 508b84d4d53e626bc8b6a6a57cd1f3b2f3c2a84d75d36c3085b4fb3d7bd9bcb3
- response sha256
- a83f066085229c55d3d0ec880c129c835ac872440e73f5fc2b7131ecfb2a254f
- retrieved at
- 2026-09-09T23:46:14.107379+00:00
- publication date
- display
- 2007 Sep 1
- precision
- day
- year
- 2007
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression.
Preserved source evidence · Not medical advice